- Home
- TFX
as 12-20-2024 4:00pm EST
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
| Founded: | 1943 | Country: | United States |
| Employees: | N/A | City: | WAYNE |
| Market Cap: | 8.4B | IPO Year: | N/A |
| Target Price: | $255.14 | AVG Volume (30 days): | 499.0K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.03 | EPS Growth: | -41.10 |
| 52 Week Low/High: | $171.69 - $256.85 | Next Earning Date: | 02-20-2025 |
| Revenue: | $3,025,824,000 | Revenue Growth: | 2.27% |
| Revenue Growth (this year): | 4.52% | Revenue Growth (next year): | 4.86% |
Latest Teleflex Incorporated News
TFX Breaking Stock News: Dive into TFX Ticker-Specific Updates for Smart Investing
TipRanks
3 days ago
Teleflex price target lowered to $200 from $227 at Truist
MT Newswires
4 days ago
Truist Securities Lowers Price Target on Teleflex to $200 From $227, Keeps Hold Rating
MT Newswires
4 days ago
RBC Cuts Price Target on Teleflex to $220 From $245, Keeps Outperform Rating
Argus Research
4 days ago
TFX: Lowering target price to $187.00
Zacks
6 days ago
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?
Simply Wall St.
9 days ago
What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?
Argus Research
11 days ago
TFX: Lowering target price to $196.00
Zacks
12 days ago
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Compare TFX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TFX Teleflex Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.